Rongchang Biotech announced that on September 11, 2026, the company repurchased 19,000 A-shares through centralized bidding transactions on the Shanghai Stock Exchange. The repurchase price range was 113.2 yuan to 113.7 yuan per share, and the total repurchase amount was 2.1552 million yuan. The repurchased shares are intended to be used in the employee equity incentive plan. If the repurchase is not used within 3 years after the implementation of the repurchase is completed, the repurchased shares that have not been used will be cancelled. As of September 11, 2026, the company has issued 355,642,060 shares and 254,184 shares in treasury.

Zhitongcaijing · 2d ago
Rongchang Biotech announced that on September 11, 2026, the company repurchased 19,000 A-shares through centralized bidding transactions on the Shanghai Stock Exchange. The repurchase price range was 113.2 yuan to 113.7 yuan per share, and the total repurchase amount was 2.1552 million yuan. The repurchased shares are intended to be used in the employee equity incentive plan. If the repurchase is not used within 3 years after the implementation of the repurchase is completed, the repurchased shares that have not been used will be cancelled. As of September 11, 2026, the company has issued 355,642,060 shares and 254,184 shares in treasury.